Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07008989 · ClinicalTrials.gov registry record · NA

A VIRTUAL Three-month Intervention Study of the Effects of a Smartphone Application (HippoCamera) on Memory in Teens and Young Adults With Down Syndrome

A NA study of Memory Replay and HippoCamera, sponsored by Boston College.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07008989 is a NA study of Memory Replay and HippoCamera that is actively recruiting participants, run by Boston College. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07008989, a NA study of Memory Replay and HippoCamera, is actively recruiting participants, sponsored by Boston College.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Down syndrome is a chromosomal abnormality associated with significant deficits across multiple cognitive domains, including a disproportionate deficit in hippocampally-dependent memory. In other words, individuals with Down syndrome may have a particular difficulty remembering specific details from past events. One way this manifests itself is in overgeneral autobiographical memory, or a tendency to remember the general gist of an event or cluster of events, rather than a single, isolated event. This overgeneral memory makes it difficult for individuals with Down syndrome to access their past, can interfere with attempts to becoming more independent, and increases anxiety and depression. In the current VIRTUAL study, the investigators test whether a new digital memory prosthetic-HippoCamera-can enhance specific autobiographical memory in individuals with Down syndrome. In HippoCamera, users are asked to record and replay events from their daily lives. This replay is curated by a research-based algorithm in HippoCamera that optimizes consolidation of these events over time and has been shown to enhance memory specificity in other populations with memory impairments, particularly those that stem from hippocampal disfunction. It is, therefore, likely that similar enhancements in autobiographical memory specificity will be identified in individuals with Down syndrome, highlighting the benefits of this applications in this population.

Interventions

  • BEHAVIORAL Memory replay

Study Locations (1)

Massachusetts

  • Boston College ONLINE STUDY - Chestnut Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-01
Est. Completion 2026-07-31
Phase NA

Sponsor

Boston College

18 total trials

What the Registry Record Tells You About NCT07008989

The ClinicalTrials.gov registry entry for NCT07008989 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston College, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Memory Replay appearing as the primary indexed condition, and to 1 intervention - of which Memory replay is the first listed.

NCT07008989 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07008989 about?

NCT07008989 is a clinical study titled "A VIRTUAL Three-month Intervention Study of the Effects of a Smartphone Application (HippoCamera) on Memory in Teens and Young Adults With Down Syndrome". Down syndrome is a chromosomal abnormality associated with significant deficits across multiple cognitive domains, including a disproportionate deficit in hippocampally-dependent memory. In other words, individuals with Down syndrome may have a particular difficulty remembering specific details from...

What is the current status of trial NCT07008989?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-01. Estimated completion is 2026-07-31.

What conditions does trial NCT07008989 study?

This clinical trial studies the following conditions: Memory Replay, HippoCamera.

What interventions are being tested in trial NCT07008989?

The interventions under investigation include: Memory replay (BEHAVIORAL).

Who is sponsoring clinical trial NCT07008989?

This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07008989 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.